Company / EPS (Diluted)
Coherus Oncology, Inc. EPS (Diluted) History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.48
FY2019
5-year range
-$16.10 / -$1.67
FY2015-FY2019
Trend
-47.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 6 years, ranging from $-16.10 in FY2015 to $-1.67 in FY2016.
Based on SEC 10-K filings.
-4.48 in FY2019.
Improved from $-6.01 to $-4.48 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (diluted) decreased 47.4% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$4.48 | -47.4% |
| FY2018 | -$3.04 | +49.4% |
| FY2017 | -$6.01 | -259.9% |
| FY2016 | -$1.67 | +89.6% |
| FY2015 | -$16.10 | -1.6% |
| FY2014 | -$15.85 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026